Sentiment Trading

Lantheus Holdings Inc. has sold its SPECT business to SHINE Technologies, allowing the company to focus on its core strengths in radiopharmaceuticals and potentially leading to innovative advancements in diagnostic imaging.

Lantheus Holdings Inc. has achieved a major milestone in Alzheimer’s imaging with its Alzheimer’s Disease Radiodiagnostic agent, MK-6240, successfully meeting co-primary endpoints in pivotal studies.

Lantheus Holdings Inc. is a leading player in the healthcare equipment and supplies sector, specializing in diagnostic medical imaging agents and poised for continued growth and innovation.